Work

Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study

Year: 2008

Type: article

Source: Genetics in Medicine

DOI: 10.1097/gim.0b013e3181863239

Authors: Iris Grossman, Patrick F. Sullivan, Nicole Walley, Youfang Liu, Jeffrey R. Dawson, Curtis Gumbs, Andrea Gaedigk, J. Steven Leeder, Joseph P. McEvoy, Michael E. Weale, David B. Goldstein

Institutions: Duke University, GlaxoSmithKline (United Kingdom), University of North Carolina at Chapel Hill, North Carolina State University, Children's Mercy Hospital, NC Department of Health and Human Services, Duke Medical Center

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, Pfizer, GlaxoSmithKline, Teva Pharmaceutical Industries, National Institutes of Health, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke

Awards: G1050801880, G1121004391, Whole-genome sequencing in multiplex epilepsy families, G4096236044, G445903376, (CHAVI) Center for HIV/AIDS Vaccine Immunology, Replication of Schizophrenia Associations in CATIE, CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES, Full Human Genome Sequencing in ALS, G8700482840

OpenAlex ID: W1966300584

FWCI: 6.981

Cites: 41

Cited by: 56

Related to: 10